Seyyedeh Ghazaleh Dashti

Seyyedeh Ghazaleh Dashti

Auto-generated profile, based on publicly available information

Seyyedeh Ghazaleh Dashti

Clinical Epidemiology and Biostatistics Unit Murdoch Children's Research Institute Melbourne Victoria Australia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Physical Activity and Health
Verified
Journal Article
Closed access
PDF file
PDPaddy C Dempsey
Paddy C Dempsey
CMChuck E. Matthews
Chuck E. Matthews
SDS. Ghazaleh Dashti
S. Ghazaleh Dashti
ADAiden R. Doherty
Aiden R. Doherty
ABAudrey Bergouignan
Audrey Bergouignan
BLBrigid M. Lynch
Brigid M. Lynch
Background: Recent updates to physical activity guidelines highlight the importance of reducing sedentary time. However, at present, only general recommendations are possible (ie, “Sit less, move more”). There remains a need to investigate the strength, temporality, specificity, and dose–response nature of sedentary behavior associations with chronic disease, along with potential underlying mechanisms. Methods: Stemming from a recent research workshop organized by the Sedentary Behavior Council themed “Sedentary behaviour mechanisms—biological and behavioural pathways linking sitting to adverse health outcomes,” this paper (1) discusses existing challenges and scientific discussions within this advancing area of science, (2) highlights and discusses emerging areas of interest, and (3) points to potential future directions. Results: A brief knowledge update is provided, reflecting upon current and evolving thinking/discussions, and the rapid accumulation of new evidence linking sedentary behavior to chronic disease. Research “action points” are made at the end of each section—spanning from measurement systems and analytic methods, genetic epidemiology, causal mediation, and experimental studies to biological and behavioral determinants and mechanisms. Conclusion: A better understanding of whether and how sedentary behavior is causally related to chronic disease will allow for more meaningful conclusions in the future and assist in refining clinical and public health policies/recommendations.

7 July 2015 in JAMA
Verified
Journal Article
Open access
PDF file
SDSeyedeh Ghazaleh Dashti
Seyedeh Ghazaleh Dashti
RCRowena Chau
Rowena Chau
DODriss Ait Ouakrim
Driss Ait Ouakrim
DBDaniel Buchanan
Daniel Buchanan
MCMark Clendenning
Mark Clendenning
AWAung Win
Aung Win
Endometrial cancer is the most common type of gynecologic cancer in developed countries.1,2 Between 2% and 5% of all endometrial cancer cases are associated with a hereditary susceptibility to cancer, mainly Lynch syndrome,3 which is an autosomal dominant disorder caused by a germline mutation in one of the DNA mismatch repair (MMR) genes MLH1 (RefSeq NM_000249), MSH2 (RefSeq NM_000251), MSH6 (RefSeq NM_000179), PMS2 (RefSeq NM_000535), and EPCAM (RefSeq NM_000535).4 Although estimates vary, the incidence of Lynch syndrome may be as high as 1 in 370 in the general population in the United States.5 Depending on the mutated gene, cumulative risk of developing endometrial cancer by age 70 years for women is thought to be between 15% and 30%.6-8 Apart from hysterectomy, there is no consensus recommendation for reducing endometrial cancer risk for women with an MMR gene mutation.9,10

24 June 2015 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
DODriss Ait Ouakrim
Driss Ait Ouakrim
SDSeyedeh Ghazaleh Dashti
Seyedeh Ghazaleh Dashti
RCRowena Chau
Rowena Chau
DBDaniel Buchanan
Daniel Buchanan
MCMark Clendenning
Mark Clendenning
AWAung Win
Aung Win
Inheritance of a germline mutation in one of the DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2 causes a high risk of colorectal and other cancers (Lynch Syndrome). Use of aspirin has been shown to be associated with a reduced risk of colorectal cancer for the general population as well as for MMR gene mutation carriers. The aim of this study was to determine whether use of aspirin and ibuprofen in a nontrial setting is associated with the risk of colorectal cancer risk for MMR gene mutation carriers. We included 1858 participants in the Colon Cancer Family Registry who had been found to have a pathogenic germline mutation in a MMR gene (carriers). We used weighted Cox proportional hazards regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). All statistical tests were two-sided. A total of 714 carriers (38%) were diagnosed with colorectal cancer at a mean age of 42.4 (standard deviation 10.6) years. A reduced risk of colorectal cancer was associated with aspirin use (for 1 month to 4.9 years: HR = 0.49, 95% CI = 0.27 to 0.90, P = .02; for ≥5 years: HR = 0.25, 95% CI = 0.10 to 0.62, P = .003) and ibuprofen use (for 1 month to 4.9 years: HR = 0.38, 95% CI = 0.18 to 0.79, P = .009; for ≥5 years: HR = 0.26, 95% CI = 0.10 to 0.69, P = .007), compared with less than one month of use. Our results provide additional evidence that, for MMR gene mutation carriers, use of aspirin and ibuprofen might be effective in reducing their high risk of colorectal cancer.

1 April 2012 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
AKArash Khojasteh
Arash Khojasteh
HBHossein Behnia
Hossein Behnia
SDSeyedeh Ghazaleh Dashti
Seyedeh Ghazaleh Dashti
MSMark Stevens
Mark Stevens

1 March 2017 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
SDS. Ghazaleh Dashti
S. Ghazaleh Dashti
DBDaniel Buchanan
Daniel Buchanan
HJHarindra Jayasekara
Harindra Jayasekara
DODriss Ait Ouakrim
Driss Ait Ouakrim
MCMark Clendenning
Mark Clendenning
AWAung Win
Aung Win
Background: People with germline mutation in one of the DNA mismatch repair (MMR) genes have increased colorectal cancer risk. For these high-risk people, study findings of the relationship between alcohol consumption and colorectal cancer risk have been inconclusive. Methods: 1,925 MMR gene mutations carriers recruited into the Colon Cancer Family Registry who had completed a questionnaire on lifestyle factors were included. Weighted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between alcohol consumption and colorectal cancer. Results: Colorectal cancer was diagnosed in 769 carriers (40%) at a mean (SD) age of 42.6 (10.3) years. Compared with abstention, ethanol consumption from any alcoholic beverage up to 14 g/day and >28 g/day was associated with increased colorectal cancer risk (HR, 1.50; 95% CI, 1.09–2.07 and 1.69; 95% CI, 1.07–2.65, respectively; Ptrend = 0.05), and colon cancer risk (HR, 1.78; 95% CI, 1.27–2.49 and 1.94; 95% CI, 1.19–3.18, respectively; Ptrend = 0.02). However, there was no clear evidence for an association with rectal cancer risk. Also, there was no evidence for associations between consumption of individual alcoholic beverage types (beer, wine, spirits) and colorectal, colon, or rectal cancer risk. Conclusions: Our data suggest that alcohol consumption, particularly more than 28 g/day of ethanol (∼2 standard drinks of alcohol in the United States), is associated with increased colorectal cancer risk for MMR gene mutation carriers. Impact: Although these data suggested that alcohol consumption in MMR carriers was associated with increased colorectal cancer risk, there was no evidence of a dose-response, and not all types of alcohol consumption were associated with increased risk. Cancer Epidemiol Biomarkers Prev; 26(3); 366–75. ©2016 AACR.

1 February 2013 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Closed access
HBHossein Behnia
Hossein Behnia
AKArash Khojasteh
Arash Khojasteh
MKMohammad Taghi Kiani
Mohammad Taghi Kiani
AKAhad Khoshzaban
Ahad Khoshzaban
FAFatemeh Mashhadi Abbas
Fatemeh Mashhadi Abbas
SDSeyedeh Ghazaleh Dashti
Seyedeh Ghazaleh Dashti